Presentations -
-
HDAC inhibition involves CD26 expression on multiple myeloma cells via the c-Myc/Sp1-mediated promoter activation and overcomes therapeutic resistance by humanized antibody
Hiroko Nishida, Reiko Suzuki, Kiyora Nakajima, Michiie Sakamoto
[International presentation] EHA 2023 Hybrid Congress (Frankfurt, Germany) ,
2023.06,Poster presentation, European Hematology Association
-
HDAC inhibition involves CD26 induction on multiple myeloma cells via the c-Myc/Sp1-mediated promoter activation and overcomes therapeutic resistance by humanized antibody.
Hiroko Nishida, Reiko Suzuki, Kiyora Nakajima, Mutusmi Hayashi, Michiie Sakamoto
[International presentation] 64th ASH Annual Meeting & Exposition (New Orleans, LA, USA) ,
2022.12,Poster presentation, American Society of Hematology
-
HDAC inhibition involves CD26 induction in myeloma cells via the Sp1-mediated promoter activation.
Hiroko Nishida, Reiko Suzuki, Mutsumi Hayashi, Michiie Sakamoto
[Domestic presentation] 84th Japanese Society of Hematology Annual Meeting (Fukuoka) ,
2022.10,Oral presentation (general), Japanese Society of Hematology
-
Isoform-selective HDAC inhibition up-regulates CD26 expression on multiple myeloma cells and augments cytotoxic efficacy by humanized monoclonal antibody.
Hiroko Nishida, Mari Fujiwara, Mutsumi Hayashi, Michiie Sakamoto
[International presentation] AACR Annual Meeting (New Orleans, LA, USA) ,
2022.04,Poster presentation, American Association for Cancer Research
-
Up-regulation of CD26 on myeloma cells by HDAC inhibition enhances the efficacy of humanized antibody
Hiroko Nishida, Mari Fujiwara, Chikao Morimoto, Michiie Sakamoto
[Domestic presentation] 83rd Japanese Society of Hematology, Annual Meeting (Sendai) ,
2021.09,Oral presentation (general), Japanese Society of Hematology
-
Humanized anti-CD26 monoclonal antibody clonogenic side population cells in multiple myeloma.
Hiroko Nishida, Mustumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
[Domestic presentation] 81th Japanese Society of Hematology Annual Meeting (Tokyo International Forum, Tokyo) ,
2019.10,Oral presentation (general), Japanese Society of Hematology
-
CD26 is a potential therapeutic target by humanized monoclonal antibody in multiple myeloma.
Hiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
[Domestic presentation] 第108回日本病理学会総会 (東京) ,
2019.05,Oral presentation (general), 日本病理学会
-
ヒト化抗CD26抗体とTriptolideの抗体薬物複合体はRNA polymeraseを阻害する
山田 健人、林 睦、西田 浩子、坂本 亨宇
[Domestic presentation] 第107回病理学会総会 (ロイトン札幌) ,
2018.06,Poster presentation, 日本病理学会
-
CD26 is a potential therapeutic target by humanized monoclonal antibody in multiple myeloma
Hiroko Nishida, Mutsumi Hayashi, Hiroshi Suzuki, Michiel Sakamoto, Taketo Yamada
[International presentation] 23rd Congress of the European Hematology Association (Stockholm, Sweden) ,
2018.06,Poster presentation, European Hematology Association
-
Humanized anti-CD26 monoclonal antibody has anti-myeloma efficacy for the treatment of multiple myeloma
Hiroko Nishida, Mutsumi Hayashi, Chikao Morimoto,Michiie Sakamoto, Taketo Yamada
[International presentation] 59th American Society of Hematology Annual Meeting & Exposition (Georgia World Congress Center, Atlanta, GA, USA) ,
2017.12,Poster presentation, American Society of Hematology
-
Humanized anti-CD26 monoclonal antibody has a therapeutic potentiality against multiple myeloma
Hiroko Nishida, Mustumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
[Domestic presentation] 79th Annual Meeting of the Japanese Society of Hematology (Tokyo International Folum, Tokyo) ,
2017.10,Oral presentation (general), Japanese Society of Hematology
-
Humanized anti-CD26 monoclonal antibody has therapeutic potential in osteolytic bone metastasis
Hiroko Nishida, Hiroshi Suzuki, Mutsumi Hayashi, Michiie Sakamoto, Taketo Yamada
[Domestic presentation] 15th Japanese Society of Medical Oncology Annual Meeting (神戸国際会議場、神戸) ,
2017.07,Oral presentation (general), the Japanese Society of Medical Oncology
-
Humanized anti-CD26 monoclonal antibody has therapeutic potential in multiple myeloma
Hiroko Nishida, Hiroshi Suzuki, Mutsumi Hayashi, Michie Sakamoto, Taketo Yamada
[Domestic presentation] 第57回リンパ網内系学会総会 (京王プラザホテル、東京) ,
2017.07,Poster presentation, 日本リンパ網内系学会
-
Novel Monoclonal Antibody Therapy Targeting CD26 in Multiple Myeloma
Hiroko Nishida, Hiroshi Suzuki, Mutsumi Hayashi, Michiie Sakamoto, Taketo Yamada
[International presentation] 22nd Congress of the European Hematology Association (Madrid, Spain) ,
2017.06,Poster presentation, European Hematology Association
-
肝癌に対するヒト化抗CD26モノクローナル抗体の抗腫瘍効果
山田健人、西田 浩子、林 睦、間所裕子、坂元亨宇
[Domestic presentation] 第106回日本病理学会総会 (京王プラザホテル、東京) ,
2017.04,Oral presentation (general), 日本病理学会
-
Isolated central nervous system relapse in type II enteropathy-associated T cell lymphoma
Hiroko Nishida, Eri Mashima, Mami Hatano, masao Hori, Katsuyuki Obara
[Domestic presentation] 78th Annual Meeting of the Japanese Society of Hematology (パシフィコ横浜) ,
2016.10,Poster presentation, 日本血液学会
-
Isolated central nervous system relapse in type II enteropathy-associated T cell lymphoma
Hiroko Nishida, Eri Massima, mami Habano, Masao Hori, Katsumyuki Obara
[Domestic presentation] 14th the Japanese Society of Medical Oncology Annual Meeting (神戸国際会議場) ,
2016.07,Poster presentation, 日本臨床腫瘍学会
-
ヒト化抗CD26モノクローナル抗体とRNAポリメラーゼII阻害剤トリプトライドの複合体の抗腫瘍効果
林睦、間所裕子、西田浩子、坂本亨宇、山田健人
[Domestic presentation] 第105回日本病理学会総会 (仙台国際センター、宮城) ,
2016.05,Oral presentation (general), 日本病理学会
-
CD26 is a novel target for the treatment of tumor progression and its related osteolytic bone disease
Hiroko Nishida, Hiroshi Suzuki, Hiroko Madokoro, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
[International presentation] 57th American Society of Hematology Annual Meeting and Exposition (Orlando,Flolida, USA) ,
2015.12,Poster presentation, American Society of Hematology
-
Blockade of CD26 signaling using humanized antibody reduces myeloma cell growth and its bone disease.
Hiroko Nishida, Hiroko Madokoro, Hiroshi Suzuki, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
[Domestic presentation] 77th Annual Meeting of the Japanese Society of Hematology (Kanazawa, Ishikawa, Japan) ,
2015.10,Oral presentation (general), Japanese Society of Hematology